Aniline and substituted anilines
1
–
1
of
1
results
1
Medchemexpress LLC 5-(3-chloro-4-cyclohexylphenyl)-1-(3-methoxyphenyl)-1H-pyrazole-3-carboxylic acid | 1393814-38-4 | MFCD26792575 | 99.7% | 410.89 g·mol-1 | C23H23ClN2O3 | 10 MG
TC LPA5 4 is a selective, non-lipid antagonist of the lysophosphatidic acid receptor 5 (LPA5/GPR92) used as a research tool to probe LPA5 signaling. It inhibits LPA-induced platelet aggregation (IC50 ≈ 0.8 μM) and has been reported to reduce proliferation and migration in certain cancer cell lines. The compound is provided with high reported purity and DMSO solubility for preparation of concentrated stock solutions.
- Selective LPA5 antagonist suitable for receptor signaling studies.
- Non-lipid, small-molecule antagonist with reported IC50 ~0.8 μM.
- Inhibits LPA-induced platelet aggregation and cell migration.
- High reported purity appropriate for biochemical and cell-based assays.
- High solubility in DMSO for convenient stock preparation.
